

Corporate Spotlight
An Emerging Global Leader in the New Generation of Anti-Infective Therapies
Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.
View the full Corporate Spotlight
RCE TO DUAL LIST on Frankfurt Stock Exchange (FSE)
Latest Threads
See All Discussions
Corporate Spotlight
- RCE TO DUAL LIST ON FSE
- RCE ADVANCES CLINICAL TRIALS BURNS STUDY
- RCE POSTS STRONG RESULTS AGAINST COVID
- RCE BANKS $900K R&D REBATE
- RCE REVEALS HIGHLIGHTS FROM DEC QTR
- RCE POSTS POSITIVE FINDINGS COVID STUDY
- RCE AWARDED ANOTHER BIG R&D REBATE
- RCE GRANTED OVERSEAS R&D KICKBACK
- RCE VIRUS TREATMENT GRANTED PATENT JAPAN
- RCE SURGES POSITIVE ANTI-COVID RESULTS
- INVESTOR PRESENATION
- RCE APPROVAL TO START BURNS STUDY
- ABOUT US
- VIDEOS
Timeline
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
View More |